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Nigella sativa or Black seed (N. sativa L.) is traditionally used for several ailments in many Middle Eastern countries. It is an
annual herbaceous plant that belongs to the Ranuculacea family with many beneﬁcial properties as antitumor, antidiabetic,
antihypertensive, antioxidative and antibacterial. This work attempted to study the eﬀect of N. sativa seeds powder and oil
on atherosclerosis in diet-induced hypercholesterolemic (HC) rabbits in comparison with simvastatin (ST). Twenty-ﬁve adult
New Zealand male white rabbits, weighing 1.5–2.5kg, were divided into ﬁve groups; normal group (NC, n = 5) and four
hypercholesterolemic groups (n = 20): a positive control (PC) and three HC groups force fed diet supplemented with
1000mgKg
−1 body weight of N. sativa powder (NSP), 500mgKg
−1 body N. sativa oil (NSO) and 10mgKg
−1 ST for 8weeks.
Feeding HC rabbits with N. sativa either in powder or oil forms was shown to signiﬁcantly reduce (P<. 05) total cholesterol
(TC) and low-density lipoprotein cholesterol (LDLC) levels and enhance high-density lipoprotein cholesterol (HDL) levels after
treatment for 2, 4, 6 and 8 weeks compared to the PC group. Plaque formation was signiﬁcantly inhibited while the intima: media
ratio was signiﬁcantly reduced in the NSP and NSO supplemented groups compared to the PC group. In conclusion, treatment of
HC rabbits with N. sativa seeds powder or oil showed hypocholesterolemic and antiatherogenic cardioprotective properties.
1.Introduction
ComplementaryandAlternativeMedicine(CAM),including
herbal medicine, is popular in the general population world-
wide [1]. Nigella sativa L., commonly known as black seeds
have been used for nutritional and medicinal purposes in
many Middle Eastern countries and other parts of the world
[2,3].SeedsoilofbothN.sativaandNeemhasbeenusedtra-
ditionally in Asia and the Middle East to treat many diseases
and several viral diseases [4, 5]. Recently, researchers have
taken interest into the seeds in diﬀerent forms: the seed itself,
the seed extract, its oil and its volatile substances. Studies
on N. sativa s e e da n di t so i lh a v ep r o v i d e ds c i e n t i ﬁ cs u p p o r t
for the traditional use of the seed and its oil for treatment
of rheumatism, immune stimulation, diabetes, cancer and
related inﬂammatory diseases [6]. Nigella sativa seeds active
constituents, for example volatile oil and thymoquinone,
showed protection against nephrotoxicity and hepatotoxicity
induced by either diseases or chemicals [7]. The seed oil
has anti-inﬂammatory, analgesic, antipyretic, antimicrobial
and antineoplastic activity [7]. Evidence concerning the
hypocholesterolemic eﬀect of N. sativa seeds in animals and
human is inconclusive.
Heart diseases remain one of the leading causes of death
worldwide [8]. Several publications produced from diﬀerent
laboratories included recommendations for a reduction
in cholesterol consumption as means of preventing these
diseases [8]. These recommendations have gained support
as the role of hypercholesterolemia in the incidence of
coronary heart diseases has been established. In addition,2 Evidence-Based Complementary and Alternative Medicine
most of the studies in this area shifted the attention to
the ways of lowering plasma cholesterol. However, few
studies have been carried out in vivo to investigate the
hypocholesterolemic properties of N. sativa seeds and their
oil. Nigella sativa seeds oil and thymoquinone have been
shown to have a hypocholesterolemic activity in rats [6, 9].
There is no available study, which examines the potential
of N. sativa in powder form and as a part of the diet on
hypercholesterolemia. Furthermore, to our knowledge, no
published study has investigated the antiatherogenic beneﬁts
ofN.sativaseedsandoil.Thereforetheaimofthisstudywas,
to investigate the hypocholesterolemic and antiatherogenic
properties of N. sativa seeds and the extracted oil on diet-
induced hypercholesterolemic in rabbits.
2. Methods
2.1. Nigella sativa Seeds Collection and Extraction. Nigella
sativa seeds were purchased from a local herbal grocery
from Taiz—a city— in the Republic of Yemen. The seeds
were cleaned and kept at 4◦C in the Laboratory of Molec-
ular Biomedicine, Institute of Bioscience, University Putra
Malaysia, Malaysia. The seeds were ground using an electric
grinder (National, model MX-915C Japan). Homogenized
and ground samples (100g) were soaked overnight with an
n-hexane (Fisher Scientiﬁc Co Ltd, Ottawa, Canada) at a
ratio of 1: 5 (w/v) and ﬁltered using the Whatman paper
(Fisher Scientiﬁc Co Ltd). The solvent was evaporated in
a vacuum rotary evaporator (Buchi, Flawil, Switzerland) at
40
◦C. The crude oil samples were combined, weighed, and
stored at −30
◦C until analysis.
2.2. Experimental Animals and Diet. Twenty-ﬁve male New
Zealand white rabbits weighing 1.25–2.5kg were used for
this study. They were housed individually in stainless steel
mesh-bottomed cages and were fed initially standard rabbits
chow pellets for 1week for adaptation. All rabbits were
maintained at almost constant environmental conditions
throughout the study at 21–24
◦C and 12h 1ight:dark cycle.
This study was carried out according to the guidelines
approved by the Animal Care and Use Committee (ACUC)
of Faculty of Medicine and Health Sciences, Universiti Putra
Malaysia.
2.3. Diet Ingredients and Preparation. The diet used was
obtained from Miba Mannsura (Malaysia), containing: soy-
bean meal (15%), corn (30%), palm kernel meal (36%),
soybean oil (2%), starch (10%), molasses (2%), mineral
mixture (3.5%), vitamins mixture (0.3%), DL-methionine
(0.2%), calcium carbonate (CaCO3), (0.5%) and calcium
phosphate (CaHPO4) (0.5%) (Table 1). Diet was mixed and
prepared in the laboratory of nutrition in Animal Sciences
Department, University Putra Malaysia. The ingredients
(soybean, corn and PKC) were ground using an electric
grinder (Manesty 3001 UK), weighed and mixed using
an electric mixer (SPAR, 107). The mineral and vitamin
mixtures, starch (10%) and oil and molasses were mixed
with cholesterol (1%) and dried in an oven at 45–50
◦C
overnight.
Table 1: Diet ingredient prepared for the experimental rabbits.
Ingredient Mixture of diet (%)
Soybean 15
Corn 30
Palm kernel meal 36
Starch 10
Molasses 2
Corn oil 2
Vitamins mixturea 0.3
Mineral mixtureb 3.5
DL-methionine 0.2
CaCO3 0.5
CaHPO4 0.5
Total 100
aThe vitamin premix provided (mgkg−1 feed): thiamin 60, riboﬂavin
22.5, niacinamide 152, calcium pantothenate 56, choline chloride 2000,
inositol 1000, folic acid 8.5, biotin 1, pyridoxine-hydrochloride 22.5, p-
aminobenzoic acid 500, Vitamin B12 0.015, DL-tocopheryl acetate 50,
menadione 4, retinyl acetate and retinyl palmitate 30 (15 000IU), cholecal-
ciferol 30 (3000IU), Vitamin C 400.
bThe mineral premix provided (mgkg−1 feed): sodium citrate dihy-
drate, FeSO4·7H2O 900, MnO2 140, KAl(SO4)2·12H2O 200, ZnSO4·H2O
125, KBr 20, NiSO4·6H2O8 . 5 ,C u S O 4·5H2O 100, CoSO4·7H2O5 ,
Na2MoO4·2H2O5 ,K I5 ,A s 2O3 0.2, NaF 8.5, Na2B4O7·10H2O5 ,
Na2SeO3·5H2O.
2.4. Chemicals and Reagents. Cholesterol and Sudan 1V were
purchased from Sigma-Aldrich, St Louis, Missouri, USA
and Simvastatin was purchased from Ranbaxy, Pharmaniga
Logisttics Sdn Bhd 260790-T, while TC, LDL, HDL and
triglycerides (TG) estimation kits were supplied by Roche
Diagnostic GmbH, d-68298 Mannheeim, Germany. Forma-
lin was obtained from BHD Chemicals and Xylene from
Ajax Chemicals, Auburn, Australia, whereas Hematoxylin
and Eosin (H&E) were purchased from Merck, Amsterdam,
The Netherlands. Absolute alcohol was bought from R&M
Chemicals, Essex, UK.
2.5. Experimental Design. The rabbits were randomly
assigned to ﬁve groups of ﬁve animals each; negative control
(NC), received a normal diet prepared and used as reference
andfourgroupsinducedwithhypercholesterolemia(n = 20)
in which rabbits were fed normal diet supplemented with
1% cholesterol for 3 weeks. Hypercholesterolemic rabbits
were further subdivided into four groups: a positive control
(PC) nontreated group, a cholesterol diet supplemented
with 1000mgkg−1 N. satvia seeds in powder form (NSP),
a cholesterol diet supplemented with 500mgkg−1 N. sativa
seeds oil (NSO) and a group force-fed cholesterol diet
supplemented with 10mgkg−1 day−1 simvastatin (ST) (dis-
solved in 4mL distilled water and was given orally) for 8
weeks. The amount of food and water was recorded daily,
while the body weight was recorded every 2 weeks.
2.6. Lipid Proﬁles Analysis. Blood samples from the ear
marginal vein of the rabbits were taken before and after 1.0%
cholesterol administration for 3 weeks, and after 2, 4, 6 and 8Evidence-Based Complementary and Alternative Medicine 3
weeks of treatment. Analysis of lipid proﬁles was carried out
using Hitachi Analyzer.
2.7. Aortic Inner Surface Lesion Formation. At the end of the
experiment, rabbits were dissected and aortas were removed,
opened longitudinally and were prepared for accurate detec-
tion and estimation of lipid deposits in the intima following
the method reported by Prasad [10]. Photographs of the
inner surface of the aorta were analyzed for the plaque
area using image-analysis software. The aortic strips were
immersedin10%formalinfor24 handrinsedbrieﬂyin70%
ethanol. The tissues were then immersed in Herxheimer’s
solution containing Sudan IV (5 g), ethyl alcohol 70%
(500mL) and acetone (500mL) at room temperature for
15min and were washed under running water for 1h. The
aortas were placed on plastic templates and the luminal
surfaces were photographed using a digital camera. The
total and atherosclerotic areas of the intimal surface of the
aorta were measured in square millimeters using an image-
analysis software. The aortic plaques were assessed blindly,
in which the scorer does not know the samples to which
group it belong, samples previously coded. The extent of
atherosclerosis was expressed as a percentage of the luminal
surface covered by atherosclerotic changes [11].
Histological analysis of the nearest part of aorta to the
heart was cut, labeled and ﬁxed in 10% formalin for a few
days and prepared for light microscopy by dehydrating the
tissue samples in an ascending series of alcohol solution for
14 h in an automatic tissue processor machine (TP1020).
The tissues were blocked, and cut using a microtome (Letiz
Wetzlar1512)to4-μmsections,pastedonslidesanddriedon
ahotplateat50–55
◦Cfor30minandthenkeptat37
◦C.H&E
were used to stain the tissue sections. Plaque accumulation
was analyzed for the average determination of the thickness
oftheintima,mediaandintima:mediaratioforthreerabbits
per group using an image-analysis system.
2.8. Statistical Analysis. Data were presented as group
means±SD and were analyzed using SPSS program version
11.0. The diﬀerences between NC and hypercholesterolemic
groups were tested by independent sample t-test. One-way
ANOVA followed by Dunnet’s Post hoc test was used to
compare the means of the PC and the treatment groups (N.
sativa in powder form group, N. sativa oil group and ST
group).
3. Results
3.1. Body Weight. Feeding rabbits with 1% cholesterol-
supplemented diet for 3 weeks resulted in a signiﬁcant
increase (P<. 05) in body weight compared to NC. Body
weight of the PC and the NC groups were shown to be
increased until the end of the experiment. On the other
hand, after 2 weeks of treatment the body weight of NSO
and NSP groups were shown to be slightly decreased and
thisphenomenonwascontinueduntiltheendofexperiment.
Similar eﬀect on body weight was observed when animals
t r e a t e dw i t hS T ,b u tt h i se ﬀect started after 4 weeks of
treatment.
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Figure 1: Changes in plasma HDL levels in 0 week, after induction
1% cholesterol for 3 weeks and after 2,4, 6 and 8 weeks of treat.
Results are expressed as means±SD of ﬁve animals per group. NSP,
Nigella satvia seeds in powder form; wk, week. Values with the same
superscript letters are not signiﬁcantly diﬀerent from each other at
P<. 05. Comparison of plasma HDL (mmol L−1) values at various
times.
3.2. Hypercholesterolemia Induction in Rabbits. Feeding rab-
bits 1% cholesterol supplemented diet resulted in a signif-
icant increase in plasma TC and LDL levels and slightly
decreased HDL levels (Tables 2 and 3 and Figure 1). In
addition, these animals had plaque formation in the abdom-
inal aorta, which led to a signiﬁcant increase (P<. 05) in
the thickness of the intima and the intima:media ratio in
cholesterol group as compared with the NC group.
3.3. Plasma Lipid Proﬁle Levels after N. sativa Seeds and Oil
and ST Treatments in Experimental Rabbits. A signiﬁcant
reduction (P<. 05) in plasma TC, LDL and TG levels of
NSP-, NSO- and ST-treated groups were observed at 2, 4,
6 and 8 weeks of treatment compared to PC group (Tables
2–4) . Treatment of rabbits with NSP and NSO was shown
to have a signiﬁcant increase (P>. 05) in plasma HDL
levels as compared to the PC group at Weeks 4, 6 and 8
of treatment. However, throughout the treatment period no
signiﬁcant diﬀerences were noticed in plasma HDL and TG
levels obtained from ST and PC groups. Plaque formation
was signiﬁcantly inhibited and the intima:media ratio was
signiﬁcantly reduced (P<. 05) in N. sativa treatment groups
and ST group as compared to the PC group. It should
be mentioned that treatment with ST-induced mortality in
rabbits (two rabbits) after 10 days of treatment and increased
liver weight and its percentage to body weight.
3.4. Assessment of Atherosclerotic Plaques. Feeding rab-
bits 1% cholesterol supplemented diet-induced plaque
formation in the abdominal aorta. The plaque area
exceeded 10.63±1.44%, 2.53± 1.06%, 2.19± 0.88% and
3.97±0.47% in the PC, NSP, NSO and ST groups, respec-
tively (Table 5). Lipid deposits in the intimal surface of the
aorta of all groups were observed in which it was stained4 Evidence-Based Complementary and Alternative Medicine
Table 2: Changes in plasma TC levels (mmol L−1) at 0 week, after feeding of 1.0% cholesterol for 3 weeks and after 2, 4, 6 and 8 weeks of
treatment.
Group Week 0 HC induction for 3 weeks Treatment period (weeks)
24 6 8
NC 0.81±0.41a 1.0±0.52a 1.29±0.58 1.06±0.40 0.88±0.3 0.60±0.26
PC 0.38±0.14a 10.33±5.1b 15.09±4.5a 13.09±3.5a 8.23±2.1a 5.41±1.3a
NSO 0.48±0.26a 10.04±3.1b 7.15±2.7b 3.59±1.9b 1.62±0.8b 0.84±0.3b
NSP 0.84±0.8a 10.70±5.4b 7.06±3.8c 4.55±2.0b 1.57±0.7b 0.64±0.3b
ST 0.31±0.1a 12.90±4.9b 9.90±1.7 b,c 6.72±1.7b 3.23±1.5b 0.67±0.6b
R e s u l t sa r ee x p r e s s e da sm e a n s±SD of ﬁve rabbits. All groups received 1% cholesterol added to the diet except for NC group. Within a column, values with
the same superscript letters are not signiﬁcantly diﬀerent from each other at P<. 05.
Table 3: Changes in plasma LDL levels (mmol L−1) at 0 week, after feeding of 1.0% cholesterol for 3 weeks and after 2, 4, 6 and 8 weeks of
treatment.
Group Week 0 HC induction for 3 weeks Treatment period (weeks)
24 6 8
NC 0.36±0.3 a 0.56±0.3a 0.36±0.2 0.37±0.2 0.29±0.1 0.24±0.1
PC 0.22±0.14a 9.20±4.9b 12.79±4.99a 10.92±4.6a 6.49± 2.2a 3.88±1.6a
NSO 0.24±0.2a 8.51±5.1b 4.46±2.2b 2.34±1.2b 1.06±0.6b 0.63±0.7b
NSP 0.43±0.2a 9.31±5.5b 5.28±3.5b 2.33±1.1b 1.16±1.4b 0.28±0.1b
ST 0.15±0.1a 12.14±8.9b 6.76±2.3a,b 4.95±2.1c 2.18±1.8b 0.42±0.2b
R e s u l t sa r ee x p r e s s e da sm e a n s±SD of ﬁve rabbits. NC group was not given cholesterol. Within a column, values with the same superscript letters are not
signiﬁcantly diﬀerent from each other at P<. 05 Comparison of plasma LDL (mmol L−1)v a l u e sa tv a r i o u sp e r i o d s .
brick red when immersed into Sudan IV (Figure 2). Plaque
formation in the whole area of the aorta was signiﬁcantly
inhibited (P<. 05) by N. sativa and ST treatments
as compared to the PC group. There was no signiﬁcant
diﬀerence (P>. 05) in the whole area examined between
treatment groups (NSP, NSO and ST).
3.5. Quantitative Analysis of Histological Data
3.5.1. Intima and Media Thickness. Thickness of the intima
in the PC group was signiﬁcantly higher (P<. 05) when
compared to NC group (Table 6 and Figure 3), but no
signiﬁcant diﬀerences were observed in the thickness of
intima of the aorta in the treatment groups (NSP, NSO
and ST) compared to NC. The PC group has shown to
have the highest value of the intima thickness, but it was
signiﬁcantlydiﬀerentonlywhencomparedwiththeNSPand
the NSO groups. On the other hand, signiﬁcant reduction
(P<. 05) in the intima thickness of the NSP and the NSO
groups in comparison with that result obtained from the ST-
treated group. The new ﬁndings showed that there were no
signiﬁcant diﬀerences observed among all the treated groups
compared to the NC group.
3.5.2. Intima:Media Ratio. The intima : media ratio in the
animals fed cholesterol was signiﬁcantly higher (P<. 05)
compared to the NC group, (Table 6 and Figure 4). The
present results showed a signiﬁcant diﬀerence (P<. 05)
between the PC group (71%) and the treatment groups (26,
33and53%intheNSP,NSOandSTgroups,resp.).However,
the intima:media ratio was observed to be signiﬁcantly
ST
NSO
NSP
PC
NC
Figure 2:Representativesphotographsoftheintimalsurfacesofthe
aortas from the ﬁve experimental groups showing Sudan IV-stained
lipid deposits. Lipid deposits are stained brick-red.
reduced in the NSP and NSO groups (P<. 05) compared
to the ST group, while there was no signiﬁcant diﬀerence
(P<. 05) in intima:media ratio observed between the NSO
and the NSP group.Evidence-Based Complementary and Alternative Medicine 5
Table 4 :C h a n g e si np l a s m aT Gl e v e l s( m m o lL −1) at 0 week, after feeding of 1.0% cholesterol for 3 weeks and after 2, 4, 6 and 8 weeks of
treatment.
Group Week 0 HC induction for 3 weeks Treatment period (weeks)
246 8
NC 0.57±0.2a 0.64±0.4a 0.54±0.2 0.72±0.2 0.52±0.27 0.64±0.4
PC 0.33±0.07b 0.32±±0.1a 0.61±0.4a 1.02±0.8a 0.79±0.6a 0.42±0.1a
NSO 0.22±0.2b 0.37±0.1a 0.60±0.3a 0.30±0.2a 0.54±0.1a 0.40±0.07a
NSP 0.34±0.2b 0.72±0.4a 0.51±0.2a 0.46±0.2a 0.50±0.1a 0.40±0.2a
ST 0.32±0.2b 0.39±0.1a 0.51±0.2a 0.65±0.4a 0.43±0.2a 0.28±0.1a
Within a column, values with the same superscript letters are not signiﬁcantly diﬀerent from each other at P<. 05. Comparison of plasma TG (mmol L−1)
values at various times.
Table 5: Percentage of lesion area in the experimental rabbits.
Group Whole area of the aorta (cm2) Area of the Atheroma (cm2) %Lesion area
PC 7.53±0.15 0.80±0.12 10.63±1.44a
NSP 6.62±0.26 0.16±0.07 2.53±1.06b
NSO 7.21±0.69 0.16±0.47 2.19±0.88b
ST 6.71±1.03 0.27±0.45 3.97±0.47b
EﬀectsofN.sativaandsimvastatintreatmentsonplaque formationintheintraluminalsurface oftheabdominalaorta.Valuesaremeans±SD(n = 5).Within
a column, values with the same superscript letters are not signiﬁcantly diﬀerent from each other (P<. 05).
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4. Discussion
Complementary and alternative medicine (CAM) has gained
a worldwide popularity over the past 20 years [12, 13].
Nigella sativa seeds have been used for nutritional and
medicinal purposes in many Middle Eastern countries and
other parts of the world [1, 14, 15]. The seeds are considered
a natural food additive and a condiment. However, they
are typically consumed mixed with honey, and in baking
products or pastries. It is evident that for most of the
hypocholesterolemic drugs to be eﬀective, they must be used
for several weeks. This may expose the patients to several
side eﬀects, especially liver injury [16]. Thus, research has
focused on the use of natural products of plant origin for the
prevention of heart diseases.
Our results showed that body weight of the PC group
was signiﬁcantly increased until the end of the experiment
compared to the NC, whereas the N. sativa treatment groups
(NSO and NSP) showed slight decrease in the body weight
during the 8 weeks of the treatment time. These results are
similar to what was found by Zaoui et al. [9], who observed
a signiﬁcant decrease (P<. 05) in body weight of normal
rats that received a daily dose of 1mgkg−1 of N. sativa ﬁxed
o i lb yo r a lg a v a g ef o r1 2w e e k s .Nigella sativa treatment of
rats (2gkg−1 day−1 of the original seed for 1 week) reported
to cause a reduction in the body weight accompanied by
signiﬁcant and sustained reduction in food intake [11]. ST
group showed a decrease in body weight starting from Week
4 of the treatment until the end of the experiment, which
might be resulted from the decreased daily food intake by
50% during the treatment time. These ﬁndings are similar to
what was reported by Zagoya et al. [17], where they observed
adecreaseinfoodintakewithweightlossofmicetreatedwith
statin.
Signiﬁcant elevation in plasma TC and LDL levels
and slight decrease in plasma HDL levels were used as
indicators of hypercholesterolemia resulted from feeding
rabbitscholesterolsupplementeddiet.Theseﬁndingswerein
the same line as with those results reported by Prasad [10].
In addition, the signiﬁcant reduction of TC and LDL levels
and enhancement of HDL levels due to N. sativa treatments
(NSO and NSP), are in agreement with the previous studies
as reported by El-Dakhakhani et al. [2, 14], who found that
feeding rats with N. sativa oil (800gkg−1 day−1)o r a l l yf o r
4 weeks caused signiﬁcant decreases in the serum LDL and6 Evidence-Based Complementary and Alternative Medicine
Table 6: Maximum thickness of the intima, media and intima : media ratio in experimental rabbits.
Group Intima thickness (μm) Media thickness (μm) Intima/media
NC 1257.02±437.68a,c,b 3791.9±1357.65a 0.34±0.04a
PC 3991.91±1598.76d 5781.4±2777.07a 0.71±0.12b
NSP 1113.48± 487.22b,a 4208.82±1393.89a 0.26±0.03a
NSO 1660.40± 96.54a 4455.54±679.94a 0.33±0.06a
ST 2311.67± 730.72c,d 4298.86±1157.51a 0.53±0.04c
Values are expressed as means±SD n = 5 for all groups. Within a column, values with the same superscript letters are not signiﬁcantly diﬀerent from each
other (P<. 05).
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Figure 4: Representative photographs of the microscopic changes from the ﬁve groups stained with E&H stain.
TG levels, and an elevation of serum HDL levels. Recently,
it was reported that the petroleum ether extract of N.
sativa signiﬁcantly reduced plasma TG and increased HDL
cholesterol [11] .T h ev o l a t i l eo i lo fN. sativa was observed
to be as eﬃcient as the cholesterol-reducing drug ST [18].
Furthermore, a study in hypercholesterolemic rats showed
that feeding rats with N. sativa oil decreased serum TC, TG
and LDL levels [9]. Additionally, treating rats with an oral
dose of 1mLkg−1 body weight of N. sativa seeds ﬁxed oil for
12weeksshowedasigniﬁcantdecreaseintotalserumTCand
TG [9].
On the other hand, our previous results [19] showed that
N. sativa seeds oil is rich in vitamin E and total antioxidant
activity, which may explain the signiﬁcant reduction in
plasma TC, LDL levels. As shown by Jorge et al. [20] vitamin
E administered to hypercholesterolemic rabbits signiﬁcantly
reduced the plasma LDL and vessel wall oxidation after 2 and
4 days of treatment, respectively, which was associated with a
decrease in vessel and plasma TC levels and an improvement
in endothelial cell functioning after 6 days [20]. It was also
found that oil extracted from N. sativa s e e d si sr i c hi n
unsaturated fatty acids, which could be responsible for the
decrease of TC and LDL cholesterol levels as reported by
other researchers [10]. The hypocholesterolimic eﬀect of N.
sativa seeds and their oil could be attributed to the seeds
contents of total dietary ﬁber (TDF), insoluble dietary ﬁber
(IDF) and soluble dietary ﬁber (SDF) as observed by Al-
Nageeb et al. [21]. In addition, it was found that several
dietary ﬁbers signiﬁcantly decrease plasma cholesterol levels
in human subjects and thereby may reduce the risk of coro-
nary heart diseases [22]. The present study demonstrated
that ST treatment (10gkg−1 day−1) signiﬁcantly decreased
TC and LDL levels when compared to the PC group over the
treatment period and these ﬁndings are in agreement with
those results obtained by other researchers [23, 24].
The results obtained from this study showed that feeding
rabbits with 1.0% of cholesterol supplemented to their diet
induced a signiﬁcant increase in the lesions as compared
to normal rabbits. In addition, our results showed that the
plaque formation in all treatment groups was signiﬁcantly
inhibited as compared to the PC group. The reduction in
atherogenesiscausedbyN.sativaseedscouldbeattributedtoEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: A hypothetical diagram to present the anti-atherogenic potential of Nigella stiava seeds and oil.
theirhighcontentofvitaminE,sinceincreasedconsumption
of vitamin E is inversely correlated with the development
of the coronary heart diseases [16]. Furthermore, vitamin E
supplementationsigniﬁcantlyreducedatheroscleroticlesions
in the ascending aorta of diet-induced hypercholesterolemic
rabbits [25]. In addition to vitamin E, the antiatherogenic
beneﬁts of N. sativa treatment (NSP and NSO) may also
be attributed to the active constituent of N. sativa seeds
(Thymoquinone) as reported recently by Ragheb et al. [26]
as well as to the high content of unsaturated fatty acids,
where it has been shown that increased consumption of
polyunsaturated fatty acids improves endothelium depen-
dent relaxation and protects against the development of
atherosclerotic cardiovascular diseases [10].
Feeding rabbits with 1% cholesterol supplemented diet-
induced atherosclerosis; however, the histological examina-
tion of normal rabbit revealed that the aorta wall has a
uniform thickness with no bulging in the lumen, and the
intima was intact without any interruption in contrast to the
hypercholesterolemic rabbits. Data from histopathological
examination of N. sativa fed rabbits revealed a signiﬁcant
inhibition of aortic atherosclerotic changes when compared
with the aorta of the PC group. In general N. sativa
treatment (NSP and NSO) showed signiﬁcant decrease in
intima : media ratio compared to ST group. It was reported
that, ST-reduced atherosclerotic plaque size and signiﬁcantly
increased the plaque content of vascular smooth muscle
cells and collagen and reduced inﬂammation contributing
to atherosclerotic plaque [27]. ST decreased the intima
thickness and signiﬁcantly decreased the intima:media ratio
by 42 and 25%, respectively, compared to the PC group [27].
TherelevanceoftheseﬁndingasshowninFigure 5depictthe
beneﬁcial role of N. Sativa powder and oil in preventing the
development of atherosclerosis.
In conclusion, this study points out to the importance
of N. sativa seeds and oil in reducing the arterial wall lipid
deposition,totalcholesterolandLDLlevelsandconsequently
the atherogenesis indicating its potential health value.
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